Metabolic Signaling
GLP-3 Triple / GLP-1 Blend
Dual agonist blend
GLP-3 Triple Agonist and GLP-1 blend
Research context
This preparation combines two incretin receptor agonists with differing receptor profiles in a single formulation. Each component is characterised independently in the published literature; the blend itself is supplied as a convenience preparation and has not been separately characterised.
Common assays: Component identity by LC-MS · Purity by RP-HPLC per component
Specification
| Designation | Dual agonist blend |
|---|---|
| Full name | GLP-3 Triple Agonist and GLP-1 blend |
| Components | GLP-3 Triple Agonist · GLP-1 |
| Formats | 15 mL Nasal Spray · 15 mL Oral Spray |
| Solubility | Supplied in metered spray format |
| Storage | Refrigerated 2–8 °C, protected from light |
Common questions
How are blend products verified analytically?
Each component is identified and quantified separately by LC-MS and RP-HPLC. The certificate reports results per component rather than as a single combined figure.
Same pathway
Related compounds
GLP-1
GLP-1 receptor agonist
A long-acting glucagon-like peptide-1 receptor agonist studied in incretin signalling research.
GLP-2 Dual Agonist
Dual GIP/GLP-1 receptor agonist
A synthetic dual agonist at both GIP and GLP-1 receptors, studied in comparative incretin signalling.
GLP-3 Triple Agonist
Triple GLP-1/GIP/glucagon receptor agonist
A synthetic triple agonist at GLP-1, GIP and glucagon receptors, studied in multi-receptor incretin research.